ScholarIQanswers from OpenAlex & ORCID
Alexandros D. Tselepis
ResearcherPublications, citations & collaboration network
Alexandros D. Tselepis is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Alexandros D. Tselepis have?
ScholarIQindexed works
Alexandros D. Tselepis has 345 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Alexandros D. Tselepis have?
ScholarIQcitation count
Alexandros D. Tselepis has 18,702 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Alexandros D. Tselepis?
ScholarIQh-index
Alexandros D. Tselepis has an h-index of 52 in OpenAlex.
What is the i10-index of Alexandros D. Tselepis?
ScholarIQi10-index
Alexandros D. Tselepis has an i10-index of 198 in OpenAlex.
What is the ORCID of Alexandros D. Tselepis?
ScholarIQorcid
The ORCID for Alexandros D. Tselepis is on the source record.
What is the OpenAlex record for Alexandros D. Tselepis?
ScholarIQopenalex
The OpenAlex for Alexandros D. Tselepis is on the source record.
What are the most-cited papers on Alexandros D. Tselepis?
ScholarIQmost cited works
2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>
François Mach, Colin Baigent, Alberico L. Catapano, Konstantinos C. Koskinas, Manuela Casula, Lina Badimón, M. John Chapman, Guy G De Backer, Victoria Delgado, Brian A. Ference, Ian M Graham, Alison Halliday, Ulf Landmesser, Borislava Mihaylova, Terje R. Pedersen, Gabriele Riccardi, Dimitrios J Richter, Marc S. Sabatine, Marja‐Riitta Taskinen, Lale Tokgozoglu, Olov Wiklund, ESC Scientific Document Group, Christian Mueller, Heinz Drexel, Victor Aboyans, Alberto Corsini, Wolfram Doehner, Michel Farnier, Bruna Gigante, Meral Kayıkçıoğlu, Goran Krstačić, Ekaterini Lambrinou, Basil S. Lewis, Josep Masip, Philippe Moulin, Steffen E. Petersen, Anna Sonia Petronio, Massimo Piepoli, Xavier Pintó, Lorenz Räber, Kausik K. Ray, Željko Reiner, Walter F. Riesen, Marco Roffi, Jean-Paul Schmid, Е. V. Shlyakhto, Iain A Simpson, Erik S.G. Stroes, Isabella Sudano, Alexandros D. Tselepis, Margus Viigimaa, Cécile Vindis, Alexander Vonbank, Michal Vrablik, Mislav Vrsalović, José Luis Zamorano, Jean-Philippe Collet, Konstantinos C. Koskinas, Manuela Casula, Lina Badimon, M. John Chapman, Guy G De Backer, Victoria Delgado, Brian A. Ference, Ian M Graham, Alison Halliday, Ulf Landmesser, Borislava Mihaylova, Terje R Pedersen, Gabriele Riccardi, Dimitrios J Richter, Marc S. Sabatine, Marja‐Riitta Taskinen, Lale Tokgozoglu, Olov Wiklund, Stephan Windecker, Victor Aboyans, Colin Baigent, Jean-Philippe Collet, Verónica Dean, Victoria Delgado, Donna Fitzsimons, Chris P Gale, Diederick E. Grobbee, Sigrun Halvorsen, Gerhard Hindricks, Bernard Iung, Peter Jüni, Hugo A. Katus, Ulf Landmesser, Christophe Leclercq, Maddalena Lettino, Basil S Lewis, Bela Merkely, Christian Mueller, Steffen E. Petersen, Anna Sonia Petronio, Dimitrios J Richter, Marco Roffi, Е. V. Shlyakhto
The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement
Vasilios G. Athyros, Theodore K. Alexandrides, Helen Bilianou, Εvangelos Cholongitas, Michael Doumas, Emmanuel S. Ganotakis, John Goudevenos, Moses Elisaf, Georgios Germanidis, Όλγα Γιουλεμέ, Asterios Karagiannis, Charalambos Karvounis, Niki Katsiki, Vasilios Kotsis, Jannis Kountouras, Evangelos Liberopoulos, Christos Pitsavos, Stergios Polyzos, Lοukianos S. Rallidis, Dimitrios Richter, Απόστολος Τσάπας, Alexandros D. Tselepis, Konstantinos Tsioufis, Κωνσταντίνος Τζιόμαλος, Themistoklis Tzotzas, Themistoklis G. Vasiliadis, Charalambos Vlachopoulos, Dimitri P. Mikhailidis, Christos S. Mantzoros